Platform
Features
Pricing
0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Employees
Links
Hugh Y. Rienhoff, Jr.
15 members
9 members
5 members
4 members
3 members
Akoya Biosciences
2 followers
Kura Oncology
20 followers
Carisma Therapeutics
1 follower
Instil Bio
insitro
6 followers
Regulus Therapeutics
REVOLUTION Medicines
5 followers
Product School
InStride
4 followers
Dyne Therapeutics
3 followers
Precigen
Explore companies